Liver Transplantation in Germany;Lebertransplantation in Deutschland

Zentralblatt fur Chirurgie

Volumn 128, Issue 10, 2003, Pages 831-841

  Wolff, M ^a   Kalff, J C ^a   Schwarz, N T ^a   Lauschke, H ^a   Minor, T ^a   Tolba, R H ^a   Hirner, A ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Liver transplantation; Living donor transplantation; Organ allocation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CARNITINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ALCOHOL LIVER CIRRHOSIS; BRAIN DEATH; CADAVER; GERMANY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LAW; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; ORGAN DONOR; OUTCOMES RESEARCH; PATIENT SELECTION; PRACTICE GUIDELINE; PROGNOSIS; RECIPIENT; RECURRENT INFECTION; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION; VIRUS INFECTION;

CADAVER; CARCINOMA, HEPATOCELLULAR; FORECASTING; GERMANY; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MULTIVARIATE ANALYSIS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; TIME FACTORS; TISSUE DONORS;

EID: 0242443893     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44344     Document Type: Review

References (73)

1. Anselmo DM, Ghobrial RM, Jung LC, Weaver M, Cao C, Saab S, Kunder G, Chen PW, Farmer DG, Yersiz H, Baquerizo A, Geevarghese S, Han SH, Goldstein L, Holt CD, Gornbein JA, Busuttil RW. New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg 2002; 235: 611-619
2. Azoulay D, Astarcioglu I, Bismuth H, Castaing D, Majno P, Adam R, Johann M. Split-liver transplantation. The Paul Brousse policy. Ann Surg 1996; 224: 737-746
3. Azoulay D, Linhares MM, Huguet E, Delvart V, Castaing D, Adam R, Ichai P, Saliba F, Lemoine A, Samuel D, Bismuth H. Decision for retransplantation of the liver: an experience- and cost-based analysis. Ann Surg 2002; 236: 713-721
4. Azoulay D, Samuel D, Ichai P, Castaing D, Saliba F, Adam R, Savier E, Danaoui M, Smail A, Delvart V, Karam V, Bismuth H. Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study. Ann Surg 2001; 234: 723-731
5. Baiocchi L, Tisone G, Palmieri G, Rapicetta M, Pisani F, Orlando G, Casciani CU, Angelico M. Hepatic steatosis: a specific sign of hepatitis C-reinfection after liver transplantation. Liver Transplantation & Surgery 1998; 4: 441-447
6. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-1619
7. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8: S14-S18
8. Berenguer M, Prieto M, Palau A, Rayon JM, Carrasco D, Juan FS, Lopez-Labrador FX, Moreno R, Mir J, Berenguer J. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. Liver Transpl 2003; 9: 228-235
9. Bizollon T, Ahmed SN, Radenne S, Chevallier M, Chevallier P, Parvaz P, Guichard S, Ducerf C, Baulieux J, Zoulim F, Trepo C. Long term histologicol improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut 2003; 52: 283-287
10. Broelsch CE, Testa G, Alexandrou A, Malago M. Living related liver transplantation: medical and social aspects of a controversial therapy. Gut 2002; 50: 143-145
11. Busque S, Esquivel CO, Concepcion W, So SK. Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Transplantation 1998; 65: 77-82
12. Busuttil RW, Goss JA. Split liver transplantation. Ann Surg 1999; 229: 313-321
13. Catena F, Nardo B, Liviano DG, Stefoni S, Arpesella G, Faenza A, Cavallari A. De novo malignancies after organ transplantation. Transplant Proc 2001; 33: 1858-1859
14. Cohen SM. Current immunosuppression in liver transplantation. American Journal of Therapeutics 2002; 9: 119-125
15. Cotterell AH, Fisher RA, King AL, Gehr TW, Dawson S, Sterling RK, Stravitz RT, Luketic VA, Sanyal AJ, Shiffman ML, Posner MP. Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent. Clinical Transplantation 2002; 16 (Suppl 7): 49-51
16. Daly I, Jain A, Reyes J, Fung J. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. Transplant Proc 2002; 34: 1503
17. Deshpande RR, Bowles MJ, Vilca-Melendez H, Srinivasan P, Girlanda R, Dhawan A, Mieli-Vergani G, Muiesan P, Heaton ND, Rela M. Results of split liver transplantation in children. Ann Surg 2002; 236: 248-253
18. Detry O, De Roover A, Honore P, Delwaide J, Jacquet N, Meurisse M. Mycophenolate mofetil monotherapy in stable liver transplant recipients with progressive renal failure. Transplant Proc 2002; 34: 782-783
19. Frilling A, Malago M, Broelsch CE. Current status of liver transplantation for treatment of hepatocellular carcinoma. Dig Dis 2001; 19: 333-337
20. Groetzner J, Kaczmarek I, Meiser B, Muller M, Daebritz S, Uberfuhr P, Reichart B. The new German allocation system for donated thoracic organs causes longer ischemia and increased costs. Thorac Cardiovasc Surg 2002; 50: 376-379
21. Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002; 347: 284-287
22. Han SH, Martin P, Edelstein M, Hu R, Kunder G, Holt C, Saab S, Durazo F, Goldstein L, Farmer D, Ghobrial RM, Busuttil RW. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transpl 2003; 9: 182-187
23. Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, Kiyosawa K, Ichida T. Successful living-related partial liver transplantation to an adult patient. Lancet 1994; 343: 1233-1234
24. Heffron TG, Smallwood GA, Davis L, Martinez E, Stieber AC. Sirolimus-based immunosuppressive protocol for calcineurin sparing in liver transplantation. Transplant Proc 2002; 34: 1522-1523
25. Hertl M, Malago M, Testa G, Broelsch CE. Structural requirements and interactions of transplant centers. World J Surg 2002; 26: 177-180
26. Jonas S, Steinmuller T, Tullius SG, Thelen A, Settmacher U, Berg T, Radtke C, Neuhaus P. Increased mortality after liver transplantation for hepatocellular carcinoma in hepatitis B-associated cirrhosis. Transpl Int 2003; 16: 33-36
27. Karliova M, Malago M, Valentin-Gamazo C, Reimer J, Treichel U, Franke GH, Nadalin S, Frilling A, Gerken G, Broelsch CE. Living-related liver transplantation from the view of the donor: a 1-year follow-up survey. Transplantation 2002; 73: 1799-1804
28. Klempnauer J, Manns MP. Hepatitis and liver transplantation. Chirurg 2000; 71: 404-409
29. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440
30. Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, Rodes J, Bruix J. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 2002; 50: 123-128
31. MacDonald A. Improving tolerability of immunosuppressive regimens. Transplantation 2001; 72: S105-S112
32. Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002; 26: 257-263
33. Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, Schmidt P, Pakrasi A, Artinian L, Murray NG, Imagawa DK, Holt C, Goldstein LI, Stribling R, Busuttil RW. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998; 28: 585-589
34. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
35. McCashland TM. Posttransplantation care: role of the primary care physician versus transplant center. Liver Transplantation 2001; 7: 2-12
36. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9: 12-18
37. Munoz SJ. Long-term management of the liver transplant recipient. Medical Clinics of North America 1996; 80: 1103-1120
38. Narayanan Menon KV, Poterucha JJ, El Amin OM, Burgart LJ, Kremers WK, Rosen CB, Wiesner RH, Charlton M. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. Liver Transplantation 2002; 8: 623-629
39. National Institutes of Health. National Institutes of Health consensus development conference: liver transplantation. Hepatology 1984; 4: 107S-110S
40. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, Shakil O, Fung JJ. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9: 239-247
41. Neuhaus P. Allocation questions in transplantation medicine. Z Arztl Fortbild Qualitatssich 2000; 94: 806-811
42. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, Weinstein JS, Murray NG, Goldstein RM, Klintmalm GB. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9: 117-123
43. Persijn GG, Cohen B. Annual report 2001. Persijn GG, Cohen B. Leiden, Eurotransplant. Annual report 2002; 54-59
44. Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. Transplantation of a donor liver to 2 recipients (splitting transplantation) - a new method in the further development of segmental liver transplantation. Langenbecks Arch Chir 1988; 373: 127-130
45. Pridohl O, Heinemann K, Hartwig T, Witzigmann H, Lamesch P, Fangmann J, Berr F, Hauss J, Kohlhaw K. Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. Transplant Proc 2001; 33: 3229-3231
46. Prince MI, Hudson M. Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages. Postgrad Med J 2002; 78: 135-141
47. Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet 1989; 2: 497
48. Raimondo ML, Dagher L, Papatheodoridis GV, Rolando N, Patch DW, Davidson BR, Rolles K, Burroughs AK. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation 2003; 75: 186-190
49. Rakela J, Vargas HE. Hepatitis-C: magnitude of the problem. Liver Transpl 2002; 8: S3-S6
50. Rela M, Muiesan P, Vilca-Melendez H, Dhawan A, Baker A, Mieli-Vergani G, Heaton ND. Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type 1. Ann Surg 1999; 229: 565-569
51. Renz JF, Ascher NL. Liver transplantation for nonviral, nonmalignant diseases: problem of recurrence. World J Surg 2002; 26: 247-256
52. Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, Miller CM, Schwartz ME. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235: 533-539
53. Rogiers X, Broering DC, Mueller L, Burdelski M. Living-donor liver transplantation in children. Langenbecks Arch Surg 1999; 384: 528-535
54. Rogiers X, Malago M, Habib N, Knoefel WT, Pothmann W, Burdelski M, Meyer-Moldenhauer WH, Broelsch CE. In situ splitting of the liver in the heart-beating cadaveric organ donor for transplantation in two recipients. Transplantation 1995; 59: 1081-1083
55. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003; 75: 425-429
56. Rosenau J, Tillmann HL, Bahr MJ, Trautwein C, Boeker KH, Nashan B, Klempnauer J, Manns MP. Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation. Transplant Proc 2001; 33: 3637-3638
57. Rückert RI. Our surgical heritage. On the history of clinical liver transplantation in Germany. Zentralbl Chir 1992; 117: 299-306
58. Schliefer K, Paar WD, Aydemir G, Wolff M, Rockstroh JK, Spengler U, Sauerbruch T. Orthotopic liver transplantation in a 33-year-old patient with fulminant hepatitis B and HIV infection. Dtsch Med Wochenschr 2000; 125: 523-526
59. Seehofer D, Rayes N, Steinmuller T, Muller AR, Jonas S, Settmacher U, Neuhaus R, Berg T, Neuhaus P. Combination prophylaxis with Hepatitis-B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance. Zeitschrift fur Gastroenterologie 2002; 40: 795-799
60. Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, Gish R, Kwo P, Balan V, Wright TL, Brass C, Rakela J. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Hepatology 2002; 36: 1253-1258
61. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, Emre S, Fishbein TM, Guy SR, Schwartz ME, Miller CM. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000; 69: 781-789
62. Smit H, Gabel D, Stracke I. Deutsche Stiftung Organtransplantation - Jahreshericht 2001. NRW. Deutsche Stiftung Organtransplantation. Jahreshericht. DSO-Verlag, Neu-Isenhurg 2002; 15-21
63. Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR, Wiesner RH, Zetterman RK. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. Transplantation 1997; 63: 1074-1079
64. Steinmüller T, Seehofer D, Rayes N, Muller AR, Settmacher U, Jonas S, Neuhaus R, Berg T, Hopf U, Neuhaus P. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002; 35: 1528-1535
65. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, Levy MF, Gonwa TA, Klintmalm GB. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000; 6: 553-561
66. Tillmann HL, Bock CT, Bleck JS, Rosenau J, Boker KH, Barg-Hock H, Becker T, Trautwein C, Klempnauer J, Flemming P, Manns MP. Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency. Liver Transpl 2003; 9: 191-196
67. Tzakis AG, Kirkegaard P, Pinna AD, Jovine E, Misiakos EP, Maziotti A, Dodson F, Khan F, Nery J, Rasmussen A, Fung JJ, Demetris A, Ruiz PJ, Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis. Transplantation 1998; 65: 619-624
68. Vivarelli M, Bellusci R, Cucchetti A, Cavrini G, De Ruvo N, Aden AA, La Barba G, Brillanti S, Cavallari A. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation 2002; 74: 1746-1751
69. Vogt DP, Henderson JM, Carey WD, Barnes D. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132: 775-780
70. Vougas V, Rela M, Gane E, Muiesan P, Melendez HV, Williams R, Heaton ND. A prospective randomised trial of bile duct reconstruction at liver transplantation: T-tube or no T-tube? Transpl Int 1996; 9: 392-395
71. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51: 248-252
72. Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent advances in liver transplantation. Mayo Clinic Proceedings 2003; 78: 197-210
73. Willems M, Metselaar HJ, Tilanus HW, Schalm SW, de Man RA. Liver transplantation and hepatitis C. Transpl Int 2002; 15: 61-67